Jeff helps investors and companies understand the market, guiding them efficiently to completing beneficial deals
Jeff is a partner in Gunderson Dettmer’s New York office. He advises venture capital, growth equity and other private equity funds on their investment activities, operations and portfolio management. He works with investment funds in both US and international transactions spanning equity and debt financings (including numerous bespoke structured equity and convertible securities offerings), secondary liquidity transactions, mergers and acquisitions, public offerings and other exit transactions, in addition to other corporate and securities law matters.
Jeff has been representing funds throughout his career. He brings extensive knowledge of the market and how evolving trends impact deals, which he uses to provide practical, real-world advice to his clients. He is an active advisor, leveraging his experience and commercial know-how to help clients anticipate problems, quickly cut to the core of thorny issues and seize opportunities. He has a track record of successful strategies to reduce complications, remove uncertainty and improve efficiency in transactions, regardless of their size and complexity.
Jeff also has deep experience representing emerging growth companies and other venture- or private equity-backed companies in many industries, such as technology, healthcare, manufacturing and energy. He combines his knowledge and results-oriented approach with Gunderson’s industry-leading experience representing companies of all stages in their financings, IPOs and M&A transactions to every engagement, including by leveraging the firm’s latest proprietary knowledge and tools.
Jeff’s representative matters include:
- Dragoneer Investment Group in:
- Amwins Group’s $1 billion recapitalization transaction
- Komodo Health’s $200 million structured equity financing
- Miro’s $400 million Series C financing
- VNLife’s $250 million Series B financing
- Maven Clinic’s $110 million Series D financing
- Multiple financings with Trumid
- D1 Capital in SKIMS’s $270 million Series C financing
- Coatue in:
- Stability AI’s $101 million financing
- Deel’s $425 million Series D financing
- Nomic AI’s $17 million financing
- A number of investment funds in transactions with SpaceX
- A consortium of investors, including D1 Capital, Tiger Global, Coatue and Dragoneer Investment Group, among others, in Lacework’s Series D financing
- Automattic in its acquisition of Texts.com
- Calibrate Health in its restructuring transaction with Madryn Asset Management
- Tithely in its:
- Acquisition of Breeze, LLC
- Sale to Accel-KKR
Jeff is a graduate of The George Washington University Law School. He also earned his bachelor’s at The George Washington University.
Education
- George Washington University Law School, J.D.
- George Washington University, B.A.